AbstractUsing pooled serum from congenitally duck hepatitis B virus (DHBV)-infected ducks as inoculum, we examined the effect of virus dose on the incubation period of infection and on the patterns of spread of virus infection in the liver. The pooled serum inoculum contained 9.5 × 109DHBV genomes per milliliter and had an infectivity titre (ID50) in newly hatched ducks of 1.5 × 1010per milliliter with a 95% confidence interval of 3.0 × 109to 6.3 × 1010ID50/ml, indicating the equivalence between one DHBV genome and one infectious unit within the limits of the assays. The incubation period of infection was inversely related to the dose of inoculum and the onset of viraemia ranged from Day 6 with the highest dose to Day 14 or 29 with the lowe...
A study was carried out to determine some of the factors that might distinguish transient from chron...
We tested the efficacy of DNA vaccines expressing the duck hepatitis B virus (DHBV) pre-surface (pre...
AbstractAs a first step in developing immuno-therapeutic vaccines for patients with chronic hepatiti...
AbstractUsing pooled serum from congenitally duck hepatitis B virus (DHBV)-infected ducks as inoculu...
Using pooled serum from congenitally duck hepatitis B virus (DHBV)-infected ducks as inoculum, we ex...
Using pooled serum from congenitally duck hepatitis B virus (DHBV)-infected ducks as inoculum, we ex...
Using pooled serum from congenitally duck hepatitis B virus (DHBV)-infected ducks as inoculum, we ex...
AbstractExperimental inoculation of naive ducks with duck hepatitis B virus (DHBV) can lead to one o...
Acute and chronic HBV infection and the resulting liver damage including hepatocellular carcinoma (H...
AbstractWe tested the efficacy of DNA vaccines expressing the duck hepatitis B virus (DHBV) pre-surf...
Experimental inoculation of naive ducks with duck hepatitis B virus (DHBV) can lead to one of three ...
Experimental inoculation of naive ducks with duck hepatitis B virus (DHBV) can lead to one of three ...
Experimental inoculation of naive ducks with duck hepatitis B virus (DHBV) can lead to one of three ...
AbstractExperimental inoculation of naive ducks with duck hepatitis B virus (DHBV) can lead to one o...
AbstractWe tested the efficacy of DNA vaccines expressing the duck hepatitis B virus (DHBV) pre-surf...
A study was carried out to determine some of the factors that might distinguish transient from chron...
We tested the efficacy of DNA vaccines expressing the duck hepatitis B virus (DHBV) pre-surface (pre...
AbstractAs a first step in developing immuno-therapeutic vaccines for patients with chronic hepatiti...
AbstractUsing pooled serum from congenitally duck hepatitis B virus (DHBV)-infected ducks as inoculu...
Using pooled serum from congenitally duck hepatitis B virus (DHBV)-infected ducks as inoculum, we ex...
Using pooled serum from congenitally duck hepatitis B virus (DHBV)-infected ducks as inoculum, we ex...
Using pooled serum from congenitally duck hepatitis B virus (DHBV)-infected ducks as inoculum, we ex...
AbstractExperimental inoculation of naive ducks with duck hepatitis B virus (DHBV) can lead to one o...
Acute and chronic HBV infection and the resulting liver damage including hepatocellular carcinoma (H...
AbstractWe tested the efficacy of DNA vaccines expressing the duck hepatitis B virus (DHBV) pre-surf...
Experimental inoculation of naive ducks with duck hepatitis B virus (DHBV) can lead to one of three ...
Experimental inoculation of naive ducks with duck hepatitis B virus (DHBV) can lead to one of three ...
Experimental inoculation of naive ducks with duck hepatitis B virus (DHBV) can lead to one of three ...
AbstractExperimental inoculation of naive ducks with duck hepatitis B virus (DHBV) can lead to one o...
AbstractWe tested the efficacy of DNA vaccines expressing the duck hepatitis B virus (DHBV) pre-surf...
A study was carried out to determine some of the factors that might distinguish transient from chron...
We tested the efficacy of DNA vaccines expressing the duck hepatitis B virus (DHBV) pre-surface (pre...
AbstractAs a first step in developing immuno-therapeutic vaccines for patients with chronic hepatiti...